A profile of tumor markers in the population of Kuwait

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2369-2372

  Al Sayer, H ^b   Al Bader, A ^c   Hussein, T ^c   Mathew, A ^c   Behbehani, A ^c   Dashti, H ^c   Farghaly, M ^c   Khorsheed, M ^c   Van Dalen, A ^a  

^a Tumour Marker Oncology   (Netherlands)

^b KUWAIT UNIVERSITY   (Kuwait)

^c NONE

Author keywords

AFP; CA 125; CA 19 9; CEA; Kuwait; Reference levels; Tumour markers

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; FEMALE; HUMAN; KUWAIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ALPHA-FETOPROTEINS; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; KUWAIT; MALE; MIDDLE AGED; NORMAL DISTRIBUTION; REFERENCE VALUES; SEX CHARACTERISTICS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032781055     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. van Dalen A: Quality control and standardization of tumour marker tests. Tumour Biol 14: 131-135, 1993.
2. Guarner J, Valdivieso E, Quintana A, Frias M, Ramirez T: CA 15.3 in breast cancer comparison of two assays and validation in a Mexican population. Arch Med Res 28: 523-526, 1997.
3. Salman T, El-Ahmady O, Tony O, Darwish M: Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients. Anticancer Res 17: 3083-3086, 1997.
4. Lopez A, Del Villar V, Ulla M, Fernandez F, Fernandez LA, Santos F, Rabadan L, Gutierrez M: Prevalence of abnormal levels of serum tumour markers in elderly people. Age Ageing 25: 45-50, 1996.
5. Takami M, Sakamoto H, Ohtani K, Takami T, Satoh K. An evaluation of CA 125 levels in 291 normal postmenopausal and 20 endometrial adenocarcinoma - bearing women before and after surgery. Cancer Lett 121: 59-72, 1997.
6. Gold P, Freedman SO: Demonstration of tumor-specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121: 439-462, 1964.
7. Bergstrand CG, Czar B: Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 8: 174, 1956.
8. Tatarinov YS: Detection of embryospecific alpha-globulin in the blood sera of patients with primary liver tumor. Vopr Med Khim 10: 90-91, 1964.
9. Bast RC Jr, Klug TL, St.John E, Jennisson E, Niloff JM, Lazarus H, Berkowitz R, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr, Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian Canaer N Engl J Med 309: 883-887, 1983.
10. Tamakoshi K, Kikkawa F, Hasegawa N, Ishikawa H, Mizuno K, Kawai M, Tomoda Y: Clinical value of a new serum tumour marker, CA 125II, in gynecologic disease. Gynecol Obstet Invest 39: 125-129, 1995.
11. Davelaar EM, van Kamp GJ, Verstraeten RA, Kenemans P: Comparison of seven immunoassays for the quantification of CA 125 antigen in serum. Clin Chem 44(7): 1417-1422, 1998.
12. Sakakara H, Kousaka T, Hattori N, Tomida K, Yao Z, Hosono M, Kobayashi H, Shirato M, Endo K, Konishi J: Dissociation in serum CA 125 concentrations measured by different monoclonal antibodies. Gynecol Oncol 52: 301-305, 1994.
13. Nustad K, Bast RC Jr, Brien TJ et al: Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. Tumour Biol 17: 196-219, 1996.
14. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski VR Jr: Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 29: 549-552, 1983.
15. Waldmann TA, McIntire KR: The use of a radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 34: 1510-1515, 1974.
16. Safi F, Kuhns V, Beger HG: Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer. Int J Biol Markers 10: 100-106, 1995.
17. van Dalen A, Kessler AC: A multicentre evaluation of tumour marker determination using the automatic enzymun. Test system ES 300 and ES 600/700. Eur J Clin Chem Clin Biochem 34: 377-384, 1996.
18. Booth SN, King JPG, Leonard JC, Dykes PW: Serum carcinoembryonic antigen in clinical disorders. Gut 14: 794-799, 1973.
19. van Dalen A. Analytical requirements and standardization of CA 15-3. Scand J Clin Lab Invest Suppl 221: 102-104, 1955.